论文部分内容阅读
目的探讨舒洛地特治疗脑血管疾病的疗效,为在临床中及时调整治疗方案。方法选择住院患者90例,年龄51-77岁,随机分为治疗组与对照组,治疗组在对照组常规治疗的情况下加用舒洛地特,治疗前后两组患者根据神经功能缺损评分及治疗后患者的病残程度,评定临床效果,采用χ~2检验进行统计分析。结果治疗后治疗组头晕、头痛、偏身运动异常、共济失调、感觉分离等均有好转,总有效率明显高于对照组,两组差异具有统计学意义(P<0.05),两组治疗后均未出现严重不良反应。结论舒洛地特对脑血管疾病具有较好的治疗效果,不良反应轻微,安全性较好。
Objective To investigate the curative effect of sulodexide on cerebrovascular diseases and to adjust the treatment plan timely in the clinic. Methods 90 hospitalized patients aged 51-77 years were randomly divided into treatment group and control group. The treatment group was treated with sulodexide in the control group. According to the neurological deficit score After treatment, the patient’s degree of disability, to assess the clinical effect, using χ ~ 2 test for statistical analysis. Results After treatment, the dizziness, headache, eccentric body movement, ataxia and sensory dissociation of the treatment group all improved, the total effective rate was significantly higher than that of the control group, the difference between the two groups was statistically significant (P <0.05) No serious adverse reactions occurred afterwards. Conclusion Schulutide has good curative effect on cerebrovascular disease with mild adverse reactions and good safety.